CVE-2021-43795

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') in com.linecorp.armeria:armeria

Description

Armeria is an open source microservice framework. In affected versions an attacker can access an Armeria server's local file system beyond its restricted directory by sending an HTTP request whose path contains `%2F` (encoded `/`), such as `/files/..%2Fsecrets.txt`, bypassing Armeria's path validation logic. Armeria 1.13.4 or above contains the hardened path validation logic that handles `%2F` properly. This vulnerability can be worked around by inserting a decorator that performs an additional validation on the request path.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.71% Top 30%
Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory github.com
Affected: line armeria
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2021-43795?
CVE-2021-43795 has been scored as a high severity vulnerability.
How to fix CVE-2021-43795?
To fix CVE-2021-43795, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-43795 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2021-43795 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-43795?
CVE-2021-43795 affects line armeria.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.